Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 6
1980 14
1981 35
1982 69
1983 45
1984 68
1985 42
1986 48
1987 31
1988 26
1989 19
1990 20
1991 15
1992 13
1993 9
1994 6
1995 9
1996 14
1997 9
1998 10
1999 9
2000 9
2001 10
2002 3
2003 6
2004 9
2005 6
2006 10
2007 9
2008 7
2009 2
2010 6
2011 6
2012 10
2013 5
2014 8
2015 6
2016 3
2017 2
2018 4
2019 4
2020 5
2021 4
2022 3
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Results by year

Filters applied: . Clear all
Page 1
Cefsulodin.
Wright DB. Wright DB. Drug Intell Clin Pharm. 1986 Nov;20(11):845-9. doi: 10.1177/106002808602001104. Drug Intell Clin Pharm. 1986. PMID: 3536385 Review.
Cefsulodin is a narrow-spectrum, third-generation cephalosporin with activity virtually restricted to Pseudomonas aeruginosa. Cefsulodin is eliminated renally and has a serum half-life similar to ceftazidime and cefoperazone. ...
Cefsulodin is a narrow-spectrum, third-generation cephalosporin with activity virtually restricted to Pseudomonas aeruginosa. Cefs …
Activity of cefsulodin and other agents against Pseudomonas aeruginosa.
Neu HC, Scully BE. Neu HC, et al. Rev Infect Dis. 1984 Sep-Oct;6 Suppl 3:S667-77. doi: 10.1093/clinids/6.supplement_3.s667. Rev Infect Dis. 1984. PMID: 6443768 Review.
Cefsulodin has a high affinity for penicillin-binding proteins of Pseudomonas aeruginosa but binds poorly to those of other bacteria. ...Cefsulodin acts synergistically with all aminoglycosides against 20%-80% of P. aeruginosa isolates....
Cefsulodin has a high affinity for penicillin-binding proteins of Pseudomonas aeruginosa but binds poorly to those of other bacteria. …
Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
Smith BR. Smith BR. Clin Pharm. 1984 Jul-Aug;3(4):373-85. Clin Pharm. 1984. PMID: 6380902 Review.
The microbiologic, pharmacokinetic, and clinical profiles of cefsulodin and ceftazidime are reviewed. Ceftazidime is a broad-spectrum beta-lactamase stable cephalosporin with excellent activity against gram-negative bacilli, including Pseudomonas aeruginosa. Cefsulodin …
The microbiologic, pharmacokinetic, and clinical profiles of cefsulodin and ceftazidime are reviewed. Ceftazidime is a broad-spectrum …
Cefsulodin and Vancomycin: A Supplement for Chromogenic Coliform Agar for Detection of Escherichia coli and Coliform Bacteria from Different Water Sources.
Schalli M, Inwinkl SM, Platzer S, Baumert R, Reinthaler FF, Ofner-Kopeinig P, Haas D. Schalli M, et al. Microorganisms. 2022 Dec 16;10(12):2499. doi: 10.3390/microorganisms10122499. Microorganisms. 2022. PMID: 36557752 Free PMC article.
Background microorganism growth on Chromogenic Coliform Agar (CCA) can be challenging. For this reason, a new alternative method with a Cefsulodin/Vancomycin (CV)-supplemented CCA should be developed in this study. ...
Background microorganism growth on Chromogenic Coliform Agar (CCA) can be challenging. For this reason, a new alternative method with a C …
Antipseudomonal beta-lactams.
Slack MP. Slack MP. J Antimicrob Chemother. 1981 Sep;8(3):165-70. doi: 10.1093/jac/8.3.165. J Antimicrob Chemother. 1981. PMID: 6270049 Review. No abstract available.
Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis.
He R, Yu ZH, Zhang RY, Wu L, Gunawan AM, Zhang ZY. He R, et al. ACS Med Chem Lett. 2015 Nov 3;6(12):1231-5. doi: 10.1021/acsmedchemlett.5b00373. eCollection 2015 Dec 10. ACS Med Chem Lett. 2015. PMID: 26713110 Free PMC article.
To facilitate mPTPB-based drug discovery, we identified alpha-sulfophenylacetic amide (SPAA) from cefsulodin, a third generation beta-lactam cephalosporin antibiotic, as a novel pTyr pharmacophore for mPTPB. ...
To facilitate mPTPB-based drug discovery, we identified alpha-sulfophenylacetic amide (SPAA) from cefsulodin, a third generation beta …
Cefsulodin kinetics in renal impairment.
Gibson TP, Granneman GR, Kallal JE, Sennello LT. Gibson TP, et al. Clin Pharmacol Ther. 1982 May;31(5):602-8. doi: 10.1038/clpt.1982.84. Clin Pharmacol Ther. 1982. PMID: 7075110
Cefsulodin kinetics were determined after a 500-mg dose to normal subjects and patients with varying degrees of renal insufficiency, including those requiring hemodialysis. ...After dialysis the elimination rate appeared to return to that in nondialysis studies. Therefore, …
Cefsulodin kinetics were determined after a 500-mg dose to normal subjects and patients with varying degrees of renal insufficiency, …
[Cefsulodin (Monaspor)].
Friis H, Holten-Andersen W. Friis H, et al. Ugeskr Laeger. 1986 Jun 23;148(26):1618-9. Ugeskr Laeger. 1986. PMID: 3750440 Danish. No abstract available.
Permeability to cefsulodin of the outer membrane of Pseudomonas aeruginosa and discrimination between beta-lactamase-mediated trapping and hydrolysis as mechanisms of resistance.
Hewinson RG, Cartwright SJ, Slack MP, Whipp RD, Woodward MJ, Nichols WW. Hewinson RG, et al. Eur J Biochem. 1989 Feb 15;179(3):667-75. doi: 10.1111/j.1432-1033.1989.tb14599.x. Eur J Biochem. 1989. PMID: 2493375 Free article.
A pair of strains of Pseudomonas aeruginosa (3-Pre: cefsulodin-sensitive, inducible beta-lactamase; and 3-Post: cefsulodin-resistant, elevated beta-lactamase, derived from 3-Pre by subculture in the presence of cefsulodin) were taken as representative of the …
A pair of strains of Pseudomonas aeruginosa (3-Pre: cefsulodin-sensitive, inducible beta-lactamase; and 3-Post: cefsulodin-res …
Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns.
Heimbach DM. Heimbach DM. Rev Infect Dis. 1984 Sep-Oct;6 Suppl 3:S744-50. doi: 10.1093/clinids/6.supplement_3.s744. Rev Infect Dis. 1984. PMID: 6443775 Clinical Trial.
The average daily dose and duration of treatment for the 37 cefsulodin-treated patients were 5.6 g and 10.3 days, respectively. ...Cefsulodin was found to be safe and comparable in efficacy to reference antibiotics in this patient population....
The average daily dose and duration of treatment for the 37 cefsulodin-treated patients were 5.6 g and 10.3 days, respectively. ... …
648 results